TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Immune Pharmaceuticals Inc (NASDAQ:IMNP) Investor Investigation Announced

  • If you purchased shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Immune Pharmaceuticals Inc
Security
NASDAQ: IMNP

Summary

April 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) was announced over potential breaches of fiduciary duties by certain officers and directors at Immune Pharmaceuticals Inc.

The investigation by a law firm concerns whether certain Immune Pharmaceuticals Inc (NASDAQ:IMNP officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

New York based Immune Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology.

Shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) declined from $5.44 per share in March 2014 to as low as $0.13 per share on March 27, 2017.

Start Monitoring Your Investments